HPRA Drug Safety Newsletter Edition 68

Download: hpra-drug-safety-newsletter-edition-68.pdf 553 KB

The latest issue of the HPRA Drug Safety Newsletter (DSN) includes important updates to support safe and appropriate use of the following medicines:

  • Ibuprofen – Review confirms small increased cardiovascular risk with daily doses at or above 2,400mg
  • Codeine – Restricted use in children and adolescents for cough and cold
  • Adverse reaction reporting- reminder
  • EU Healthcare Professional Survey-have your say on how safety recommendations for medicines are communicated


« Back